Stay updated on Rucaparib Pembrolizumab Maintenance in Stage IV NSCLC Clinical Trial
Sign up to get notified when there's something new on the Rucaparib Pembrolizumab Maintenance in Stage IV NSCLC Clinical Trial page.

Latest updates to the Rucaparib Pembrolizumab Maintenance in Stage IV NSCLC Clinical Trial page
- Check6 days agoChange DetectedRevision history on the study page was updated to add revision v3.5.3 and remove v3.5.2.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. No visible changes to the study details or page layout.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check42 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. This update appears to be a system/UI refresh and does not modify study details, eligibility criteria, or results.SummaryDifference0.1%

- Check56 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed.SummaryDifference0.1%

- Check77 days agoChange DetectedThe study status is updated to terminated due to financial hardships, and results have been posted with dates and linked documents. The prior Active, not recruiting status and earlier submission notes were removed.SummaryDifference2%

- Check84 days agoChange DetectedRevision tag updated to v3.4.2 is now shown. The lapse-in-government-funding notice and the prior Revision: v3.4.1 text were removed.SummaryDifference0.5%

Stay in the know with updates to Rucaparib Pembrolizumab Maintenance in Stage IV NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rucaparib Pembrolizumab Maintenance in Stage IV NSCLC Clinical Trial page.